# Heart Watch Study: a Pragmatic Randomized Controlled Trial

Study · id `cardio:ct-nct04468321` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04468321](<https://clinicaltrials.gov/study/NCT04468321>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04468321

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

## Technical summary

Registry record NCT04468321. Randomized; no masking; primary purpose other. Start 2021-08-18 (actual); primary completion 2023-12-01 (actual). Results posted on 2024-12-20.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT04468321, source copy `cardio:ctgov-nct04468321-2025-04-18`, retrieved 2026-10-26)
- Started: 2021-08-18 (actual) (ClinicalTrials.gov record NCT04468321, source copy `cardio:ctgov-nct04468321-2025-04-18`, retrieved 2026-10-26)
- Primary completion: 2023-12-01 (actual) (ClinicalTrials.gov record NCT04468321, source copy `cardio:ctgov-nct04468321-2025-04-18`, retrieved 2026-10-26)
- Completion: 2024-06-01 (actual) (ClinicalTrials.gov record NCT04468321, source copy `cardio:ctgov-nct04468321-2025-04-18`, retrieved 2026-10-26)
- Results first posted: 2024-12-20 (ClinicalTrials.gov record NCT04468321, source copy `cardio:ctgov-nct04468321-2025-04-18`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04468321, source copy `cardio:ctgov-nct04468321-2025-04-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04468321-2025-04-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Heart Watch Study: a Pragmatic Randomized Controlled Trial
- Condition: Cardioversion
- Condition: Atrial Fibrillation
- Intervention (Device): Apple Watch
- Intervention (Device): Withings Move
- Lead sponsor: Yale University
- Lead sponsor class: OTHER
- Collaborator: Mayo Clinic
- Collaborator class: OTHER
- Collaborator: Duke University
- Collaborator class: OTHER
- Collaborator: National Evaluation System for health Technology Coordinating Center
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Yale University (`cardio:org-yale-university`)
- Registry lists this organization as a collaborator: Mayo Clinic (`cardio:org-mayo-clinic`)
- Registry lists this organization as a collaborator: Duke University (`cardio:org-duke-university`)

## Provenance

Content hash: 98e01027ad997056992790d8e41ecfb05f5d36e0a1e6a7a7269a35aea328de74
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
